openPR Logo
Press release

Biosimilars Market By Top Players - Pfizer (US), Sandoz (Germany), Teva Pharmaceuticals (Israel), Amgen (US), Biocon (India), Dr. Reddy’s Laboratories (India), Celltrion (South Korea), and Samsung Biologics (South Korea)

05-29-2019 03:37 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Verified Market Research

Biosimilars Market By Top Players - Pfizer (US), Sandoz

Global Biosimilars Market Analysis

According to Verified Market Research, the global biosimilars market was valued at USD 5.62 Billion in 2018 and is projected to reach USD 47.57 Billion by 2026, growing at a CAGR of 30.43 % from 2019 to 2026.

What are Biosimilars?

Biosimilar is a biological medical product also referred to as follow-on biologic or subsequent entry biologic. It is basically an identical copy of an original product manufactured by a different company. It is officially approved version of original innovative products and manufactured only when the original product’s patent expires. Its production is based on living organisms or cells and it comprises a complex molecular structure.

Get | Download Sample Copy @ https://www.verifiedmarketresearch.com/download-sample/?rid=8889&utm_source=op&utm_medium=Ranu&utm_campaign=Ranu

Global Biosimilars Market Outlook

In the report, the market outlook section mainly encompasses the fundamental dynamics of the market which include drivers, restraints, opportunities, and challenges faced by the industry. Drivers and Restraints are intrinsic factors whereas opportunities and challenges are extrinsic factors of the market.
Traditionally, the patents of several blockbuster biological drugs had expired and further, more biologic drugs are expected to lose their patent protection over the coming years.

Due to this, global biosimilars markets would eventually boost up giving tremendous opportunities to biosimilar manufacturers. Also, government cost-saving initiatives and use of third-party players have encouraged the use of biosimilar products over the branded and known biologics. Some of the other factors like the growing population and prevalence of chronic diseases are responsible for the growing demand for biosimilars. However, negative perceptions from physicians, patent extensions and lower price in comparison to small molecule generics limit the biosimilars market.

Obtain Report Details @ https://www.verifiedmarketresearch.com/download-sample/?rid=8889&utm_source=op&utm_medium=Ranu&utm_campaign=Ranu

Verified Market Research narrows down the available data using primary sources to validate the data and use it in compiling a full-fledged market research study. The report contains a quantitative and qualitative estimation of market elements which interests the client. The “Global BIOSIMILARS Market” is mainly bifurcated into sub-segments which can provide classified data regarding the latest trends in the market.

Global Biosimilars Market Competitive Landscape

The “Global Biosimilars Market” study report will provide a valuable insight with an emphasis on global market including some of the major players such as Pfizer (US), Sandoz (Germany), Teva Pharmaceuticals (Israel), Amgen (US), Biocon (India), Dr. Reddy’s Laboratories (India), Celltrion (South Korea), and Samsung Biologics (South Korea). Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

Get Sample copy @ https://www.verifiedmarketresearch.com/download-sample/?rid=8889&utm_source=op&utm_medium=Ranu&utm_campaign=Ranu

About us-

Verified Market Research’ has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. Our large database includes the latest Content from renowned authors and publications worldwide. We’ve recently developed a one of its own kind smart-system, which helps us determine the authenticity and reputation of the content and its author. This ‘smart-system’ ensures that we always include high – quality content in our database. We also provide customized Data and Reports according to the need of our client. We strive for excellence and perfection in all our work, and our in-house team is working 24/7 so that you get the Data, Reports, and Analytics you need to help make better decisions. We believe in Customer Satisfaction, and to achieve that we aim to understand the client’s need to provide ‘tailor-made’ services.

Our aim is to save your Time and Resources, providing you with the required Research Data, so you can only concentrate on Progress and Growth. Our Data includes research from various industries, along with all necessary statistics like Market Trends, or Forecasts from reliable sources.

Contact us -

Mr. Edwyne Fernandes

Call: +1 (650) 781 4080

sales@verifiedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biosimilars Market By Top Players - Pfizer (US), Sandoz (Germany), Teva Pharmaceuticals (Israel), Amgen (US), Biocon (India), Dr. Reddy’s Laboratories (India), Celltrion (South Korea), and Samsung Biologics (South Korea) here

News-ID: 1756732 • Views:

More Releases from Verified Market Research

Automotive Chassis Market Anticipated to Grow to USD 109.46 Billion by 2031 | Key Players: ZF Friedrichshafen AG, Magna International Inc., Continental AG, Aisin Seiki Co., Ltd., Hyundai Mobis, Benteler International AG, Gestamp Automoción
Automotive Chassis Market Anticipated to Grow to USD 109.46 Billion by 2031 | Ke …
USA, New Jersey: According to Verified Market Research analysis, the Automotive Chassis Market size was valued at USD 74.79 Billion in 2024 and is expected to reach USD 109.46 Billion by 2032, growing at a CAGR of 5.44% from 2026 to 2032. The growth of the Automotive Chassis Market is increasingly influenced by the adoption of AI and automation technologies, which are driving efficiency, precision, and scalability across the sector.
Automotive Catalytic Converter Market Expected to Surpass USD 361.76 Billion Mark by 2031 | Major Contributors: BASF SE, BENTELER International Aktiengesellschaft, BM Catalysts Limited, BOSAL, Marelli Corporation, Calsonic Kansei, Deccats, Eberspächer,
Automotive Catalytic Converter Market Expected to Surpass USD 361.76 Billion Mar …
USA, New Jersey: According to Verified Market Research analysis, the Automotive Catalytic Converter Market size was valued at USD 196.61 Billion in 2024 and is projected to reach USD 361.76 Billion by 2032, growing at a CAGR of 7.92% from 2026 to 2032. The growth of the Automotive Catalytic Converter Market is increasingly influenced by the adoption of AI and automation technologies, which are driving efficiency, precision, and scalability across
Automotive Biometric Vehicle Access System Market Size to Reach USD 13.96 Billion by 2031 | Key Players: Robert Bosch GmbH, Continental AG, Denso Corporation, Valeo SA, Synaptics Incorporated, Aptiv PLC, Mitsubishi Electric Corporation, Nuance Communicati
Automotive Biometric Vehicle Access System Market Size to Reach USD 13.96 Billio …
USA, New Jersey: According to Verified Market Research analysis, theAutomotive Biometric Vehicle Access System Market size was valued at USD 4.63 Billion in 2024 and is projected to reach USD 13.96 Billion by 2032, growing at a CAGR of 14.8% during the forecast period 2026-2032. The growth of the Automotive Biometric Vehicle Access System Market is increasingly influenced by the adoption of AI and automation technologies, which are driving efficiency,
Automotive Battery Management System Market Projected to Achieve USD 22.03 billion Valuation by Key Players: LG Energy Solution, Samsung SDI, Panasonic Corporation, BYD Company Ltd., Robert Bosch GmbH, Denso Corporation, Continental AG, Analog Devices Inc
Automotive Battery Management System Market Projected to Achieve USD 22.03 billi …
USA, New Jersey: According to Verified Market Research analysis, the Automotive Battery Management System Market size was valued at USD 6.6 Billion in 2024 and is projected to be reached at USD 22.03 Billion by 2032, with a CAGR of 16.27% being expected from 2026 to 2032. The growth of the Automotive Battery Management System Market is increasingly influenced by the adoption of AI and automation technologies, which are driving

All 5 Releases


More Releases for Biosimilar

Interchangeable Biosimilar Humira Market Share Driven by Biologic Therapy Adopti …
Interchangeable Biosimilar Humira Market The global market for Interchangeable Biosimilar Humira was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period View sample report https://reports.valuates.com/request/sample/QYRE-Auto-33I15005/Global_Interchangeable_Biosimilar_Humira_Market_Research_Report_2023 The Interchangeable Biosimilar Humira Market is experiencing significant market growth as healthcare providers and patients increasingly adopt biosimilar therapies for autoimmune and inflammatory conditions. Market trends indicate rising
Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025: Advance …
What Are the Projections for the Size and Growth Rate of the Biosimilar Monoclonal Antibodies Market? In recent times, the biosimilar monoclonal antibodies sector has experienced a swift expansion. The market size, which stands at $8.04 billion in 2024, is projected to climb to $9.25 billion in 2025, marking a compound annual growth rate (CAGR) of 15.1%. Factors such as expired patents, an increased understanding of biosimilars, governmental strategies, heightened financial
Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025: Advance …
What Are the Projections for the Size and Growth Rate of the Biosimilar Monoclonal Antibodies Market? In recent times, the biosimilar monoclonal antibodies sector has experienced a swift expansion. The market size, which stands at $8.04 billion in 2024, is projected to climb to $9.25 billion in 2025, marking a compound annual growth rate (CAGR) of 15.1%. Factors such as expired patents, an increased understanding of biosimilars, governmental strategies, heightened financial
Biosimilar Market Treating More for Less: The Booming Infliximab Biosimilar Mark …
Infliximab Biosimilar Market worth $ XX Million by 2030 - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Infliximab Biosimilar Market- by Application (Crohn's Disease, Psoriatic Arthritis, Rheumatoid Arthritis, Ulcerative Colitis, Ankylosing Spondylitis, Plaque Psoriasis and Others), End User (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Direct Distribution Channels), Trends, Industry Competition Analysis, Revenue and Forecast To 2030." Get
Biosimilar Monoclonal Antibodies Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " "Global Biosimilar Monoclonal Antibodies Market by Product (infliximab, trastuzumab, rituximab, adalimumab, bevacizumab, cetuximab, ranibizumab, denosumab, eculizumab, and other pipeline products), Indication (oncology, inflammatory & autoimmune disorders, chronic diseases, blood disorders, and other indications), Clinical Trial/Pipeline Analysis, Future Trends, Industry Competition Analysis, Revenue and Forecast To 2031." The Biosimilar Monoclonal Antibodies Market Size is valued at 5.02
Infliximab Biosimilar Insight, 2022 | DelveInsight
DelveInsight's, "Infliximab Biosimilar Insight, 2022" report provides comprehensive insights about 35+ companies and 45+ marketed and pipeline drugs in Infliximab Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Interested to know more about the functioning of